Fintel reports that on November 6, 2024, Raymond James upgraded their outlook for Masimo (NasdaqGS:MASI) from Market Perform ...

Masimo delivered Q3 results that mostly aligned with guidance, yet it faces challenges in its non-healthcare segment.

A lawsuit against pulse oximeter manufacturers and distributors is starting to create change. But experts say the FDA needs ...

We recently published a list of 8 Most Promising Medical Stocks According to Hedge Funds. In this article, we are going to ...

Vanderbilt University Medical Center is launching Masimo Radius VSM™ advanced wireless patient-worn vital signs monitoring ...

Apple won the case, though was only awarded a nominal $250, which is the smallest amount it was possible for the court to order. In other words, yes Masimo did in infringe Apple’s patents, but there ...

This is the latest development in the long legal battle between Masimo, a medical tech firm, and Apple in which the former alleges the latter unlawfully incorporated its pulse oximetry tech into the ...

We want them to stop copying our design.” He criticized Masimo for focusing on its innovations in pulse oximetry—technology that measures blood oxygen levels—arguing that the infringement still ...

The intense legal feud between Apple and medical technology company Masimo has reached a pivotal moment with Apple ... tech giants and health technology firms are set to redefine the scope of personal ...

We want them to stop copying our design” and features,” Apple attorney said, lambasting Masimo for focusing on its innovations in pulse oximetry, the blood-oxygen measurement feature.

Apple said in a statement that it was "glad the jury's decision today will protect the innovations we advance on behalf of our customers." ...